Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1807]

Combination therapeutic strategies for aRCC patients with bone metastases

Prof Stéphane Oudard and Dr Stefanie Zschäbitz

Combination therapeutic strategies for aRCC patients with bone metastases ( Prof Stéphane Oudard and Dr Stefanie Zschäbitz )

ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas

Dr Rohit Thummalapalli - Memorial Sloan Kettering Cancer Center, New York, USA

ZL-1310 shows promising activity in DLL3-positive neuroendocrine carcinomas ( Dr Rohit Thummalapalli - Memorial Sloan Kettering Cancer Center, New York, USA )

DLL3 expression in circulating tumour cells predicts response to tarlatamab in...

Dr Avanish Mishra - Krantz Family Center for Cancer Research, Boston, USA

DLL3 expression in circulating tumour cells predicts response to tarlatamab in small cell lung cancer ( Dr Avanish Mishra - Krantz Family Center for Cancer Research, Boston, USA )

Development and challenges for T-cell engagers as a novel treatment for lung...

Dr May-Lucie Meyer - Lausanne University Hospital, Lausanne, Switzerland

Development and challenges for T-cell engagers as a novel treatment for lung cancer and mesothelioma ( Dr May-Lucie Meyer - Lausanne University Hospital, Lausanne, Switzerland )

TQB2922 combination shows high response rates in EGFR-mutant lung cancer after...

Dr Jinhui Xue - Sun Yat-sen University Cancer Center, Guangzhou, China

TQB2922 combination shows high response rates in EGFR-mutant lung cancer after tyrosine kinase inhibitor resistance ( Dr Jinhui Xue - Sun Yat-sen University Cancer Center, Guangzhou, China )

Artificial intelligence PD-L1 scoring matches pathologists and improves...

Prof Fred Hirsch - Icahn School of Medicine at Mount Sinai, New York, USA

Artificial intelligence PD-L1 scoring matches pathologists and improves reproducibility in lung cancer testing ( Prof Fred Hirsch - Icahn School of Medicine at Mount Sinai, New York, USA )

Cracking the code: Bispecific immunotherapy in small cell lung cancer

Prof Helena Linardou - Metropolitan Hospital, Athens, Greece

Cracking the code: Bispecific immunotherapy in small cell lung cancer ( Prof Helena Linardou - Metropolitan Hospital, Athens, Greece )

Rituximab-based chemotherapy achieves strong outcomes without routine...

Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany

Rituximab-based chemotherapy achieves strong outcomes without routine radiotherapy in stage I extranodal large B-cell lymphoma ( Dr Konstantinos Christofyllakis - Saarland University, Saarbrücken, Germany )

Durvalumab plus chemotherapy improves outcomes and urine tumour DNA predicts...

Dr Michiel van der Heijden - Netherlands Cancer Institute, Amsterdam...

Durvalumab plus chemotherapy improves outcomes and urine tumour DNA predicts response in muscle-invasive bladder cancer ( Dr Michiel van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

Zolbetuximab plus nivolumab and chemotherapy shows promising responses in...

Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan

Zolbetuximab plus nivolumab and chemotherapy shows promising responses in CLDN18.2-positive metastatic gastric cancer ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )

EAU 2026: Updates in NMIBC

Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra...

EAU 2026: Updates in NMIBC ( Dr Francesco Soria, Prof Jonathan Aning, Dr Antoni Vilaseca and Prof Alexandra Masson-Lecomte )

Circulating tumour DNA shows high accuracy for monitoring testicular cancer...

Dr Dalia Kaakour - University of California, Irvine, USA

Circulating tumour DNA shows high accuracy for monitoring testicular cancer across all stages ( Dr Dalia Kaakour - University of California, Irvine, USA )

More from ecancer